Key benefits of large-scale use of universal over conventional flu vaccines

December 15, 2016, Public Library of Science

Universal vaccines that protect against multiple strains of influenza virus at once could offer key population-level benefits over conventional seasonal vaccines, according to a new study published in PLOS Computational Biology.

Flu-causing viruses are continually evolving. To keep up, scientists must update vaccines regularly so that people can be protected against whichever seasonal pose the greatest risk. However, researchers are working to develop universal vaccines that could protect against multiple flu strains without needing to be updated.

Research on universal flu vaccines has mostly focused on their potential effects in individual patients. To better understand their effects at the population level, Rahul Subramanian of The University of Chicago and colleagues mathematically modeled the interactions between vaccination, , and flu virus evolution.

The model revealed that deployment of universal vaccines across large populations could reduce flu transmission more efficiently than conventional vaccines. It could also slow the evolution of new strains of and bolster herd immunity, protecting against the emergence of especially dangerous pandemic strains.

"New influenza vaccines could, for the first time, maintain their effectiveness in the face of viral evolution," Subramanian says. "In doing so they could transform the way we manage influenza in future."

However, conventional vaccines that are well-matched against circulating flu strains are highly effective and are likely to continue to play an important role. Subramanian says that an optimal approach may be to strategically use universal vaccines alongside conventional vaccines to protect at-risk groups while controlling transmission in the whole population.

Explore further: UGA, Sanofi Pasteur develop new vaccine for H1N1 influenza

More information: Subramanian R, Graham AL, Grenfell BT, Arinaminpathy N (2017) Universal or Specific? A Modeling-Based Comparison of Broad-Spectrum Influenza Vaccines against Conventional, Strain-Matched Vaccines. PLoS Comput Biol 13(1): e1005204. DOI: 10.1371/journal.pcbi.1005204

Related Stories

UGA, Sanofi Pasteur develop new vaccine for H1N1 influenza

March 29, 2016
Researchers at the University of Georgia and Sanofi Pasteur, the vaccines division of Sanofi, announced today the development of a vaccine that protects against multiple strains of both seasonal and pandemic H1N1 influenza ...

New, more effective strategy for producing flu vaccines

December 5, 2016
A team of researchers led by Yoshihiro Kawaoka, professor of pathobiological sciences at the University of Wisconsin-Madison School of Veterinary Medicine, has developed technology that could improve the production of vaccines ...

Study suggests potential hurdle to universal flu vaccine development may be overcome

August 15, 2012
In the quest for a universal influenza vaccine—one that elicits broadly neutralizing antibodies that can protect against most or all strains of flu virus—scientists have faced a sobering question: Does pre-existing ...

Stepping closer to a universal flu vaccine

October 7, 2016
Researchers at McMaster University and two American universities have taken another step closer to developing a much more effective, "one-punch" universal flu vaccine.

A new approach to predict evolution of influenza viruses can enhance vaccine efficacy

December 7, 2015
New results from a study performed at the University of Helsinki suggest that genomic information from circulating influenza viruses can help in producing more efficient seasonal vaccines. The researchers were able to develop ...

Intranasal flu vaccine produces long-lasting immune response in mice

July 19, 2016
Intranasal flu vaccines may be able to provide long-lasting protection against pandemic flu strains, according to a new study from immunologists at Columbia University Medical Center (CUMC).

Recommended for you

New long-acting approach for malaria therapy developed

January 22, 2018
A new study, published in Nature Communications, conducted by the University of Liverpool and the Johns Hopkins University School of Medicine highlights a new 'long acting' medicine for the prevention of malaria.

Virus shown to be likely cause of mystery polio-like illness

January 22, 2018
A major review by UNSW researchers has identified strong evidence that a virus called Enterovirus D68 is the cause of a mystery polio-like illness that has paralysed children in the US, Canada and Europe.

Creation of synthetic horsepox virus could lead to more effective smallpox vaccine

January 19, 2018
UAlberta researchers created a new synthetic virus that could lead to the development of a more effective vaccine against smallpox. The discovery demonstrates how techniques based on the use of synthetic DNA can be used to ...

Study ends debate over role of steroids in treating septic shock

January 19, 2018
The results from the largest ever study of septic shock could improve treatment for critically ill patients and save health systems worldwide hundreds of millions of dollars each year.

New approach could help curtail hospitalizations due to influenza infection

January 18, 2018
More than 700,000 Americans were hospitalized due to illnesses associated with the seasonal flu during the 2014-15 flu season, according to federal estimates. A radical new approach to vaccine development at UCLA may help ...

Flu may be spread just by breathing, new study shows; coughing and sneezing not required

January 18, 2018
It is easier to spread the influenza virus (flu) than previously thought, according to a new University of Maryland-led study released today. People commonly believe that they can catch the flu by exposure to droplets from ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.